UBS O'Connor’s Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 ANAC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-128,545
Closed -$103K – 1149
2021
Q4
$103K Buy
128,545
+3,447
+3% +$2.73K ﹤0.01% 833
2021
Q3
$95K Hold
125,098
– – ﹤0.01% 832
2021
Q2
$128K Buy
+125,098
New +$107K ﹤0.01% 792

Other funds holding ANAC.WS

UBS O'Connor's ANAC.WS Position: Q1 2022 in Review

UBS O'Connor sold out of Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (ANAC.WS) in Q1 2022, closing a stake of 128,545 shares — an estimated $103K sold.

UBS O'Connor first reported a position in ANAC.WS in Q2 2021 and held it in 3 quarters. The position peaked at $128K in Q2 2021. 54 funds tracked by Wall St. Rank hold ANAC.WS as of Q1 2022.

  • UBS O'Connor reported no remaining Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2022 after selling out during the quarter.
  • UBS O'Connor sold 128,545 Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2022, an estimated $103K.
  • UBS O'Connor first reported a position in Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q2 2021 and held it in 3 quarters.
  • UBS O'Connor's Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $128K in Q2 2021.
  • 54 funds tracked by Wall St. Rank held Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2022.

Based on UBS O'Connor's 13F filing for Q1 2022, filed 16 May 2022.